Compare CRDF & UBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRDF | UBCP |
|---|---|---|
| Founded | 1999 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.5M | 80.3M |
| IPO Year | 2012 | 1995 |
| Metric | CRDF | UBCP |
|---|---|---|
| Price | $0.89 | $14.43 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.28 | N/A |
| AVG Volume (30 Days) | ★ 413.2K | 6.5K |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | ★ 6.54% |
| EPS Growth | ★ 27.37 | 5.51 |
| EPS | N/A | ★ 0.69 |
| Revenue | ★ $365,993.00 | N/A |
| Revenue This Year | N/A | $2.21 |
| Revenue Next Year | $8.70 | $6.72 |
| P/E Ratio | ★ N/A | $21.16 |
| Revenue Growth | ★ 49.61 | N/A |
| 52 Week Low | $0.76 | $12.55 |
| 52 Week High | $3.31 | $17.34 |
| Indicator | CRDF | UBCP |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 49.49 |
| Support Level | $0.76 | $13.37 |
| Resistance Level | $1.13 | $16.08 |
| Average True Range (ATR) | 0.08 | 0.56 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 35.89 | 59.49 |
Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, to overcome treatment resistance and deliver improved clinical outcomes for patients.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.